id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2025-N-6743-2004,FDA,FDA-2025-N-6743,Effects of Testosterone Treatment in Older Men,Supporting & Related Material,Background Material,2026-04-20T04:00:00Z,2026,4,,,2026-04-20T17:33:25Z,,0,0,09000064b9292bf7
FDA-2025-N-6743-2003,FDA,FDA-2025-N-6743,Effect of Testosterone Replacement Therapy on Sexual Function and Hypogonadal Symptoms in Men with Hypogonadism,Supporting & Related Material,Background Material,2026-04-20T04:00:00Z,2026,4,,,2026-04-20T17:32:17Z,,0,0,09000064b9292bf6
FDA-2025-N-6743-2002,FDA,FDA-2025-N-6743,Potential New Indication for Testosterone Replacement Therapy,Notice,Announcement,2026-04-20T04:00:00Z,2026,4,2026-04-20T04:00:00Z,,2026-04-20T17:25:47Z,2026-07615,0,0,09000064b9293dfa
FDA-2025-N-6743-0001,FDA,FDA-2025-N-6743,Food and Drug Administration Expert Panel on Testosterone Replacement Therapy for Men; Request for Information,Notice,Requests for Information (RFI),2025-12-11T05:00:00Z,2025,12,2025-12-11T05:00:00Z,2026-02-10T04:59:59Z,2026-02-20T20:29:54Z,2025-22466,0,0,09000064b90c309f